Position in MRK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,977,189,536
+$1,872,505,841 QoQ
Shares Held
15,386,689
+1668.1% QoQ
Ownership
0.624%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#24
of 3,778 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital International Investors holds $21,276,574,646 across 8 Drug Manufacturers - General names. MRK ranks #4 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,734,768 | $6,878,453,355 | |
| 2 | AZN |
Astrazeneca PLC
|
34,576,070 | $6,556,314,393 | |
| 3 | ABBV |
AbbVie Inc.
|
15,638,631 | $3,935,305,104 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
15,386,689 | $1,977,189,536 | |
| 5 | AMGN |
Amgen Inc
|
1,668,778 | $604,297,889 | |
| 6 | JNJ |
Johnson & Johnson
|
2,040,519 | $518,230,610 | |
| 7 | NVO |
Novo Nordisk A S
|
9,721,180 | $466,033,369 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,913,752 | $340,750,390 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,977,189,536 | 15,386,689 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $104,683,695 | 870,261 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $90,600,966 | 860,735 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $284,805,376 | 3,393,368 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $321,783,421 | 4,064,975 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $432,087,136 | 4,813,805 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $624,809,010 | 6,280,750 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $716,012,379 | 6,305,146 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $771,517,886 | 6,231,970 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $794,847,403 | 6,023,853 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $17,214,803 | 157,905 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $15,837,416 | 153,836 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $41,402,393 | 358,804 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $37,774,939 | 355,061 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $107,068,414 | 965,015 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $82,786,294 | 961,290 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $87,428,930 | 958,966 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $153,474,442 | 1,870,499 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $1,294,268,882 | 16,887,642 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,721,922,212 | 22,925,339 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,248,756,568 | 28,915,476 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,557,803,947 | 33,179,434 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,834,421,731 | 34,650,648 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,169,840,407 | 38,213,851 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,787,476,746 | 36,046,496 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,144,288,594 | 27,869,632 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||